Survival in patients on hemodialysis: Effect of gender according to body mass index and creatinine

• Published in: PloS one Vol. 13; no. 5; p. e0196550
• Main Authors: Park, Jeung-Min, Lee, Jong-Hak, Jang, Hye Min, Park, Yeongwoo, Kim, Yon Su, Kang, Shin-Wook, Yang, Chul Woo, Kim, Nam-Ho, Kwon, Eugene, Kim, Hyun-Ji, Lee, Ji-Eun, Jung, Hee-Yeon, Choi, Ji-Young, Park, Sun-Hee, Kim, Chan-Duck, Cho, Jang-Hee, Kim, Yong-Lim
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 16.05.2018; Public Library of Science (PLoS)
• Subjects: Analysis; Biology and Life Sciences; Body composition; Body mass; Body mass index; Body size; Care and treatment; Chronic kidney failure; Complications and side effects; Confidence intervals; Creatinine; Dialysis; Gender; Health aspects; Hemodialysis; Investigations; Medicine and Health Sciences; Mortality; Nutrition; Obesity; Patient outcomes; Patients; Physiological aspects; Risk analysis; Risk factors; Statistical models; Survival; South Korea
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0196550

The association of a higher body mass index (BMI) with better survival is a well-known "obesity paradox" in patients on hemodialysis (HD). However, men and women have different body compositions, which could impact the effect of BMI on mortality. We investigated the effect of gender on the obesity-mortality relationship in Korean patients on HD. This study included 2,833 maintenance patients on HD from a multicenter prospective cohort study in Korea (NCT00931970). The relationship between categorized BMI and gender-specific mortality was evaluated by an adjusted Cox proportional hazard model with restricted cubic spline analyses and the Competing risk analysis. We also investigated the effect of changes in BMI over 12 months and serum creatinine level on survival in male and female patients on HD. The mean BMI was 22.6 ± 3.3 kg/m2 and the mean follow up duration was 24.2 ± 3.4 months. The patients with the highest quintile of BMI (≥25.1 kg/m2) showed lower mortality (subdistributional hazard ratio [SHR] = 0.63, 95% confidence interval [CI] = 0.43-0.93, P = 0.019) compared with those with the reference BMI quintile. When analyzed by gender, male patients with a BMI over 25.1 kg/m2 had lower mortality risk (HR = 0.43, 95% CI = 0.25-0.75, P = 0.003); however, no significant difference was found in female patients. Increased BMI after 12 months and high serum creatinine were associated with better survival only in male patients on HD. BMI could be used as a risk factor for mortality in male patients on HD. However, the mortality of female patients on HD was not related with baseline and follow-up BMI. This suggests that BMI is a good surrogate marker of lean body composition, especially in male patients on HD.